{ "model": { "rank": 5782, "code": "thing-q193216", "model_id": "vr.tr.trachoma", "name": "trachoma", "purpose": "Enable an AI agent to recognise evidence of trachoma, distinguish current inflammation and infection from lasting ocular damage, and support appropriate clinical referral and population-control decisions.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.STA", "industry": "", "version": "", "url": "/models/thing/q193216/", "tier": 2, "score": 65, "payload": { "layer": "wikidata", "aliases": [], "aliasCount": 0, "merged": 0, "knownIn": 65, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": "vr.tr.trachoma", "source": { "dataset": "wikidata", "item": "Q193216", "url": "https://www.wikidata.org/wiki/Q193216", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-07T09:18:04Z", "providers": [ "Codex" ], "missingProviders": [ "Grok" ], "pass": 2, "cost": { "grok": { "usd": null, "turns": null, "seconds": 10.7, "error": "Error: Internal error: {\n \"message\": \"API error (status 402 Payment Required): Grok Build usage balance exhausted\",\n \"http_status\": 402\n}", "retried": true }, "codex": { "seconds": 104.9, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.3\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a07b27-7ca6-7681-8d64-7f6677771f3b\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: trachoma\nRegistry id: vr.tr.trachoma\nPlane / domain: ACT / ACT.ACT\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\nA Vercy" } } }, "metaModel": { "id": "THING-Q193216", "registryId": "vr.tr.trachoma", "name": "trachoma", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "ACT.ACT" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q193216/", "model": { "registry_id": "vr.tr.trachoma", "name": "trachoma", "purpose": "Enable an AI agent to recognise evidence of trachoma, distinguish current inflammation and infection from lasting ocular damage, and support appropriate clinical referral and population-control decisions.", "definition": "", "scope_statement": "This model owns the recognition, observed state, progression, transmission context and action requirements of trachoma under vr.tr.trachoma, linking eye-level assessments to person-level histories and population-level evidence without treating these as interchangeable.", "in_scope": [ "Clinical evidence supporting or challenging attribution to trachoma", "Independent recording of active inflammation, conjunctival scarring, trichiasis and corneal opacity in each eye", "Ocular infection evidence and its relationship to clinical signs", "Repeated exposure, disease progression and trachoma-attributable visual impairment", "Indications, delivery and outcomes of trachoma-specific interventions", "Population burden, surveillance and evidence supporting elimination assessments" ], "out_of_scope": [ "General classification and management of conjunctivitis from other causes", "Urogenital chlamydial infection and its sexual-health management", "The complete biology and taxonomy of Chlamydia trachomatis", "Detailed surgical technique, prescribing protocols and pharmaceutical supply chains", "General water, sanitation and housing infrastructure design", "Comprehensive blindness rehabilitation and unrelated causes of visual impairment" ], "distinguishing_features": [ "Examine the upper tarsal conjunctiva: redness or discharge alone does not establish trachoma; record the distribution of follicles, inflammation and scarring.", "Apply explicit grading criteria: WHO TF requires at least five follicles of at least 0.5 mm in the central upper tarsal conjunctiva. [WHO diagnosis](https://www.who.int/teams/control-of-neglected-tropical-diseases/trachoma/diagnosis)", "Distinguish clinical trachoma from laboratory-detected ocular chlamydial infection; a positive organism test alone does not establish the characteristic disease history or exclude another chlamydial conjunctivitis presentation.", "For lashes touching the eye or corneal opacity, record evidence of a trachomatous cause and competing explanations rather than attributing all trichiasis or opacity to trachoma.", "Keep active inflammatory signs separate from established scarring and mechanical damage; an eye with lasting sequelae need not have demonstrable current infection." ], "characteristics": [ { "name": "Assessment subject and laterality", "kind": "relation", "unit_or_values": "Person and right or left eye; population observations linked separately to a defined evaluation unit", "why_it_matters": "Prevents one eye's findings or a district's prevalence from being assigned to another eye or to an individual." }, { "name": "Trachoma attribution", "kind": "category", "unit_or_values": "Suspected, supported, uncertain or alternative explanation favoured; record the case definition and evidence", "why_it_matters": "Makes the basis of recognition explicit without inventing a universal confirmation rule." }, { "name": "Simplified clinical signs", "kind": "state", "unit_or_values": "TF, TI, TS, TT and CO independently present, absent, uncertain or not assessed for each eye", "why_it_matters": "These signs can coexist and should not be forced into a single sequential stage." }, { "name": "Ocular infection evidence", "kind": "category", "unit_or_values": "Detected, not detected, indeterminate or not tested; specimen site, assay and collection date", "why_it_matters": "Separates microbiological evidence from inflammatory signs and historical damage." }, { "name": "Lash contact and epilation", "kind": "measurement", "unit_or_values": "Number and location of upper-lid lashes touching the globe; evidence and timing of recent epilation", "why_it_matters": "Documents mechanical risk and avoids interpreting removed lashes as resolution of the underlying problem." }, { "name": "Visual function", "kind": "measurement", "unit_or_values": "Visual acuity per eye using a named scale, correction status and assessment date", "why_it_matters": "Tracks functional consequences while preserving uncertainty about their cause." }, { "name": "Exposure and intervention history", "kind": "relation", "unit_or_values": "Dated links to residence, household exposure, prior examinations, antibiotics, epilation and eyelid surgery", "why_it_matters": "Supports interpretation of recurrence, persistent damage and possible reinfection." }, { "name": "Population burden", "kind": "measurement", "unit_or_values": "Indicator-specific prevalence in percent, with numerator, denominator, age group, survey date, uncertainty and evaluation unit", "why_it_matters": "Keeps estimates comparable and prevents an unrepresentative case count from becoming a programme decision." }, { "name": "Care pathway status", "kind": "state", "unit_or_values": "Assessment needed, referred, offered, accepted, deferred, declined, delivered or follow-up due, with reason and date", "why_it_matters": "Distinguishes an identified need from completed care and records unresolved barriers." } ], "affordances": [ "Organise examination and laboratory evidence into a traceable trachoma assessment.", "Compare dated eye examinations to identify new inflammation, scarring or recurrent lash contact.", "Flag findings requiring clinician assessment and track referral completion.", "Support authorised selection and monitoring of trachoma interventions using applicable guidance.", "Aggregate eligible observations into population indicators with explicit denominators and uncertainty.", "Identify evidence gaps that prevent a diagnosis, treatment decision or elimination claim." ] }, "sources": [], "structure": { "bundles": [ { "id": "recognition-and-attribution", "name": "Recognition and attribution", "description": "Establish what supports identifying an observation as trachoma and what remains ambiguous.", "rationale": "Follicular conjunctivitis, ocular chlamydial infection and scar-related eyelid disease are overlapping observations rather than interchangeable diagnoses.", "layers": [ { "id": "clinical-recognition", "name": "Clinical recognition", "description": "Connect the observed conjunctival pattern to an explicit recognition rule.", "findings": [ { "id": "trachoma-case-basis", "name": "Trachoma case basis", "description": "Record the examined eye, observed signs, examiner and case definition supporting attribution.", "questions": [ { "text": "Which upper tarsal conjunctival findings support trachoma under the stated case definition?", "kind": "definition", "id": "trachoma-case-basis-q01" }, { "text": "Who examined the eye, when, and with what grading training and examination conditions?", "kind": "provenance", "id": "trachoma-case-basis-q02" } ] } ] }, { "id": "infection-and-differential", "name": "Infection and differential", "description": "Separate organism detection from disease attribution and consider competing explanations.", "findings": [ { "id": "clinical-laboratory-concordance", "name": "Clinical and laboratory concordance", "description": "Preserve agreement or disagreement between clinical signs, ocular testing and the exposure history.", "questions": [ { "text": "What ocular specimen and assay, if any, support current infection, and how does collection timing relate to examination and antibiotics?", "kind": "provenance", "id": "clinical-laboratory-concordance-q01" }, { "text": "What evidence distinguishes this presentation from other follicular conjunctivitides, including other chlamydial ocular presentations?", "kind": "boundary", "id": "clinical-laboratory-concordance-q02" } ] } ] } ] }, { "id": "ocular-signs-and-damage", "name": "Ocular signs and damage", "description": "Describe inflammation and structural consequences independently for each eye.", "rationale": "Current inflammation and established damage imply different needs and cannot be represented reliably by one severity label.", "layers": [ { "id": "inflammation-and-scarring", "name": "Inflammation and scarring", "description": "Record TF, TI and TS separately using a named grading standard.", "findings": [ { "id": "independent-conjunctival-signs", "name": "Independent conjunctival signs", "description": "Capture follicles, inflammatory vessel obscuration and visible scarring without assuming every sign must occur in sequence. [WHO grading criteria](https://www.who.int/teams/control-of-neglected-tropical-diseases/trachoma/diagnosis)", "questions": [ { "text": "For each eye, which TF, TI and TS criteria are present, absent or impossible to assess?", "kind": "measurement", "id": "independent-conjunctival-signs-q01" }, { "text": "Do differences from earlier examinations reflect changed findings, a different grader or inadequate examination quality?", "kind": "provenance", "id": "independent-conjunctival-signs-q02" } ] } ] }, { "id": "mechanical-and-visual-consequences", "name": "Mechanical and visual consequences", "description": "Connect eyelid abnormalities and corneal findings to functional harm without assuming causation.", "findings": [ { "id": "lash-cornea-and-vision-assessment", "name": "Lash, cornea and vision assessment", "description": "Record upper-lid lash contact or recent epilation, corneal opacity, visual acuity and evidence for trachomatous attribution.", "questions": [ { "text": "Which lashes touch the globe, what recent epilation is evident, and what corneal findings and visual acuity are recorded in each eye?", "kind": "measurement", "id": "lash-cornea-and-vision-assessment-q01" }, { "text": "Which evidence links the eyelid or corneal damage to trachoma, and which alternative causes require assessment?", "kind": "boundary", "id": "lash-cornea-and-vision-assessment-q02" }, { "text": "Do pain, new visual loss or suspected corneal injury require expedited clinical assessment under the applicable referral pathway?", "kind": "action", "id": "lash-cornea-and-vision-assessment-q03" } ] } ] } ] }, { "id": "exposure-and-disease-course", "name": "Exposure and disease course", "description": "Place findings within repeated exposure and a dated history of inflammation and damage.", "rationale": "A single examination cannot establish the history of recurrent exposure or explain persistent sequelae.", "layers": [ { "id": "transmission-context", "name": "Transmission context", "description": "Record plausible opportunities for exposure and prevention needs without assigning individual blame.", "findings": [ { "id": "ocular-secretions-and-household-exposure", "name": "Ocular secretions and household exposure", "description": "Link relevant contact, facial cleanliness, water and sanitation observations to possible transmission opportunities. [WHO trachoma overview](https://www.who.int/news-room/fact-sheets/detail/trachoma)", "questions": [ { "text": "What dated observations describe contact with ocular or nasal secretions, household clustering and residence in affected communities?", "kind": "provenance", "id": "ocular-secretions-and-household-exposure-q01" }, { "text": "Which observed barriers to facial cleanliness, water access or sanitation could a prevention programme address?", "kind": "action", "id": "ocular-secretions-and-household-exposure-q02" } ] } ] }, { "id": "longitudinal-course", "name": "Longitudinal course", "description": "Distinguish persistent signs, newly observed disease and sequelae after treatment.", "findings": [ { "id": "persistence-recurrence-and-progression", "name": "Persistence, recurrence and progression", "description": "Compare dated clinical and infection evidence while leaving unobserved intervals and mechanisms unresolved.", "questions": [ { "text": "Which examinations document resolution, persistence, new scarring or recurrent lash contact?", "kind": "measurement", "id": "persistence-recurrence-and-progression-q01" }, { "text": "What evidence supports reinfection, persistent infection, residual inflammation or postoperative recurrence, and what remains indistinguishable?", "kind": "boundary", "id": "persistence-recurrence-and-progression-q02" } ] } ] } ] }, { "id": "safe-interventions-and-follow-up", "name": "SAFE interventions and follow-up", "description": "Connect identified needs to surgery, antibiotics, facial cleanliness and environmental improvement under the SAFE strategy. [WHO prevention and control](https://www.who.int/news-room/fact-sheets/detail/trachoma)", "rationale": "Infection control, protection from lash-related injury and prevention of further exposure require distinct actions and outcome measures.", "layers": [ { "id": "intervention-selection", "name": "Intervention selection", "description": "Identify which action is supported, at which level, and by whose authority.", "findings": [ { "id": "indication-and-eligibility", "name": "Indication and eligibility", "description": "Separate individual care indications from population antibiotic decisions and record the applicable protocol.", "questions": [ { "text": "Which findings support trichiasis referral, individual infection management or assessment for population antibiotic intervention?", "kind": "action", "id": "indication-and-eligibility-q01" }, { "text": "Which current local protocol, eligibility factors and authorised clinician or programme decision govern the proposed intervention?", "kind": "provenance", "id": "indication-and-eligibility-q02" } ] } ] }, { "id": "delivery-and-outcomes", "name": "Delivery and outcomes", "description": "Track completed care and reassessment against the problem each intervention addresses.", "findings": [ { "id": "care-completion-and-residual-need", "name": "Care completion and residual need", "description": "Record treatment or referral completion, barriers, adverse outcomes and continuing ocular or prevention needs.", "questions": [ { "text": "Was the indicated intervention offered and delivered, and what explains any delay, refusal or incomplete coverage?", "kind": "action", "id": "care-completion-and-residual-need-q01" }, { "text": "At follow-up, what evidence shows changed inflammation, infection, lash contact, visual function or continued exposure?", "kind": "measurement", "id": "care-completion-and-residual-need-q02" } ] } ] } ] }, { "id": "population-burden-and-elimination", "name": "Population burden and elimination", "description": "Represent survey evidence and programme status separately from individual diagnoses.", "rationale": "Elimination decisions depend on defined populations, indicator-specific evidence and continuing care capacity rather than the absence of reported cases.", "layers": [ { "id": "survey-indicators", "name": "Survey indicators", "description": "Preserve the age groups, sampling methods and definitions behind trachoma prevalence estimates.", "findings": [ { "id": "tf-and-tt-population-estimates", "name": "TF and TT population estimates", "description": "Distinguish TF prevalence in children aged 1-9 years from TT prevalence in people aged 15 years and older, including the required health-system-awareness classification. [WHO trachoma questions and answers](https://www.who.int/news-room/questions-and-answers/item/trachoma)", "questions": [ { "text": "What are the evaluation unit, survey dates, sampling method, age-specific denominators and uncertainty for each estimate?", "kind": "measurement", "id": "tf-and-tt-population-estimates-q01" }, { "text": "How were TT cases classified with respect to being known to the health system, and were grading and adjustment methods comparable across surveys?", "kind": "provenance", "id": "tf-and-tt-population-estimates-q02" } ] } ] }, { "id": "programme-status-and-surveillance", "name": "Programme status and surveillance", "description": "Attach elimination assessments to their governing criteria, geography, date and ongoing surveillance obligations.", "findings": [ { "id": "elimination-evidence-and-continuing-care", "name": "Elimination evidence and continuing care", "description": "Distinguish elimination as a public health problem from absence of infection or absence of people needing care.", "questions": [ { "text": "Which dated criteria and evidence support the recorded elimination status, and which authority assessed or validated it?", "kind": "provenance", "id": "elimination-evidence-and-continuing-care-q01" }, { "text": "What system continues to detect and manage incident TT and investigate evidence of renewed transmission?", "kind": "action", "id": "elimination-evidence-and-continuing-care-q02" } ] } ] } ] } ] }, "openQuestions": [ "Does an existing Vercy world model already own trachoma, requiring vr.tr.trachoma to link to it rather than create another publication?", "Which diagnostic and referral rules should resolve discordant clinical signs and ocular infection tests in the intended jurisdictions?", "Which evidence is sufficient to attribute trichiasis or corneal opacity to trachoma when conjunctival scarring or reliable history is unavailable?", "Which current national and WHO guidance versions govern antibiotic programme decisions, surveillance and elimination assessment for the intended evaluation units?", "Which follow-up intervals and outcome definitions should distinguish residual inflammation, reinfection, progressive scarring and postoperative trichiasis?" ], "statistics": { "bundles": 5, "layers": 10, "findings": 10, "questions": 21 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a trachoma, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an AI agent to recognise evidence of trachoma, distinguish current inflammation and infection from lasting ocular damage, and support appropriate clinical referral and population-control decisions.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Described in 65 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a trachoma, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [], "standing": "Described in 65 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one trachoma from another, and a trachoma from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a trachoma sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a trachoma from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a trachoma passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a trachoma between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a trachoma, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a trachoma is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What trachoma is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of trachoma are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is trachoma operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of trachoma and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of trachoma?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as trachoma?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a trachoma came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a trachoma and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a trachoma is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a trachoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a trachoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a trachoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }